COVID-19 IMI2–Call 21
CARE launched to accelerate therapy development against COVID-19 and future coronavirus threats.
Search
Boosting performance with an inclusive performance culture
Inclusive leaders and an inclusive organisation allow diversity to flourish. Diversity is the mix. Inclusion is making the mix work. Learn more here.
COVID-19 Southeast Asia Support of Healtvare Community
Learn more about what Boehringer Ingelheim is doing to assist health workers in managing the pandemic in Southeast Asia. Click here to find out more.
COVID-19 USA Partnership ensures jobs & feeds community
Boehringer Ingelheim & partners feed the hungry, first responders and manufacturing employees still working onsite. Click here to learn more.
The Angels Initiative
The Angels Initiative is a unique healthcare initiative to improve acute care for people who have just suffered a stroke. Click here to learn more.
Be green Japan
Boehringer Ingelheim's Yamagata site is gradually switching to a more sustainable energy supply. Click here to find out more information about this.
COVID-19 Italy for isolated patients to keep contact
300 tablets donated to hospitals in Italy where patients isolated due to COVID-19 are fighting for recovery to let them feel less alone. Learn more here.
Webinars for clinicians on needs of vulnerable respiratory
Webinars with more than 1,000 HCPs to provide an update on prevention and treatment recommendations for vulnerable respiratory patients. Learn more here.
Dortmund
Boehringer Ingelheim has a research and production network across the globe. Click here to read and find out information about our Dortmund site.
Commits to Thoracic Society’s COVID-19 Fund
Boehringer Ingelheim is committing USD 500,000 (around EUR 458,000) to the American Thoracic Society (ATS) and its COVID-19 Crisis Fund. Learn more here.
COVID-19 Psychological support for HCPs
Boehringer Ingelheim Spain offers psychological support to health professionals in order to take care of their emotional health in these difficult times.
Empowering all employees
Boehringer Ingelheim has been awarded as a Global Top Employer for the second year in succession. Find out more about why we are a Global Top Employer.
Bees and biodiversity
At Boehringer Ingelheim we attach great importance to sustainable planting on our company site – and to protecting the bees. Click here to find out more.
COVID-19 Boehringer Ingelheim Thailand equips frontline
Boehringer Ingelheim Thailand is working together with the Thai Department of Disease Control during the pandemic. Click here to learn more.
COVID-19 Material donations in Germany
Boehringer Ingelheim donates protective equipment and disinfectants to authorities and social institutions at the company's German sites during COVID-19.
REACH / GHS / Material safety data sheets
European and international chemical legislations like REACH and GHS impact Boehringer Ingelheim's activities in many different ways. Learn more here.
COVID-19: Global Support Program - Oceania
Here you can find out about our work to support Oceania during the COVID-19 pandemic. Click here to find out and learn more about the support.
COVID-19: Global Support Program - Middle East & Africa
Here you can find out about our work to support the Middle East & Africa during the pandemic. Click here to find out and learn more about the support.
COVID-19: Global Support Program - Asia
Click here to find out about our COVID-19 support in Asia. This page contains links to a number of articles with information about our support.
COVID-19: Global Support Program - Europe
Here you can find out about our work to support countries in Europe during the pandemic. Click here to find out and learn more about the support.
Production Insights
Boehringer Ingelheim makes an important contribution to the reliable and sustainable supply of pharmaceuticals. Click here to learn and find out more.
The Supplier Code of Conduct
Read about Boehringer Ingelheim's expectations towards its suppliers on ethical behaviour, integrity, professionalism and common business requirements.
More Potential Overview
More Potential works to provide the best conditions for our people, communities and partners along our value chain. Click here to find out more.
COVID-19 Q&A for Patients
Corona and COVID-19 can lead to many questions. We want to answer a few of them, provide some general information and give some recommendations.
Boehringer Ingelheim's Board of Managing Directors | Boehringer Ingelheim
Read more about Boehringer Ingelheim's board of managing directors, with information on all five members and their respective responsibilities.